Easterly Investment Partners LLC Buys 183,387 Shares of Quanterix Co. (NASDAQ:QTRX)

Easterly Investment Partners LLC grew its stake in Quanterix Co. (NASDAQ:QTRX - Free Report) by 26.5% in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 876,133 shares of the company's stock after buying an additional 183,387 shares during the quarter. Easterly Investment Partners LLC owned 2.28% of Quanterix worth $11,355,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently made changes to their positions in the stock. nVerses Capital LLC bought a new stake in shares of Quanterix in the third quarter worth $60,000. SG Americas Securities LLC bought a new stake in shares of Quanterix in the third quarter worth $139,000. Canada Pension Plan Investment Board bought a new stake in Quanterix during the second quarter worth $140,000. Hsbc Holdings PLC raised its position in Quanterix by 34.7% during the second quarter. Hsbc Holdings PLC now owns 12,738 shares of the company's stock worth $164,000 after acquiring an additional 3,279 shares in the last quarter. Finally, Comerica Bank raised its position in Quanterix by 44,205.6% during the first quarter. Comerica Bank now owns 7,975 shares of the company's stock worth $188,000 after acquiring an additional 7,957 shares in the last quarter. Institutional investors and hedge funds own 86.48% of the company's stock.

Analyst Ratings Changes

Several analysts have issued reports on the stock. TD Cowen dropped their price target on shares of Quanterix from $17.00 to $15.00 and set a "hold" rating on the stock in a research report on Friday, August 9th. Scotiabank dropped their price target on shares of Quanterix from $32.00 to $28.00 and set a "sector outperform" rating on the stock in a research report on Monday, August 12th.

Quanterix Price Performance

Shares of NASDAQ:QTRX traded up $0.01 on Friday, hitting $15.10. The company had a trading volume of 332,230 shares, compared to its average volume of 396,321. Quanterix Co. has a 1-year low of $10.50 and a 1-year high of $29.70. The stock has a 50 day moving average price of $12.82 and a 200 day moving average price of $14.07.

Quanterix (NASDAQ:QTRX - Get Free Report) last released its quarterly earnings data on Thursday, August 8th. The company reported ($0.25) EPS for the quarter, missing the consensus estimate of ($0.23) by ($0.02). Quanterix had a negative net margin of 30.71% and a negative return on equity of 11.52%. The company had revenue of $34.38 million during the quarter, compared to analyst estimates of $34.19 million. During the same quarter in the prior year, the firm earned ($0.16) earnings per share. Equities analysts expect that Quanterix Co. will post -0.88 earnings per share for the current year.

Insider Activity at Quanterix

In other Quanterix news, Director David R. Walt purchased 47,000 shares of the firm's stock in a transaction that occurred on Tuesday, August 20th. The shares were acquired at an average cost of $13.29 per share, for a total transaction of $624,630.00. Following the completion of the purchase, the director now owns 1,487,342 shares of the company's stock, valued at approximately $19,766,775.18. The trade was a 0.00 % increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. 6.90% of the stock is currently owned by corporate insiders.

About Quanterix

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications.